Superiority of Ambulatory Over Clinic Blood Pressure Measurement in Predicting Mortality: The Dublin Outcome Study

By E. Dolan, A. Stanton, L. Thijs, K. Hinedi, N. Atkins, Sean P. McClory, E. Hond, P. McCormack, J. Staessen, E. O'Brien. HYPERTENSION, 2005

1,255 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

European Society of Hypertension position paper on ambulatory blood pressure monitoring. (2013, background): “Observational studies have shown that ABPM monitoring predicts the incidence of cardiovascular morbid or fatal events [16,126,218,225,226].”
A Randomized, Phase 3 Trial of Naltrexone SR/Bupropion SR on Weight and Obesity-related Risk Factors (COR-II) (2013, background): “Importantly, the normal diurnal variation was maintained; nocturnal lowering in blood pressure is considered an important predictor of cardiovascular outcomes (20-21).”
Pathophysiology of sleep apnea. (2010, background): “Restoration of this normal circadian blood pressure pattern is an important benefit of CPAP because daytime cardiovascular events and complications are more prevalent in individuals who lack sleep-related falls in blood pressure (134, 697).”
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, methodology): “Out-of-office measures (ambulatory BP monitoring and home BP monitoring) have been shown to have a stronger association with cardiovascular events than office BP measurement.(34,86,91-99) Ambulatory BP monitoring and home BP monitoring have high diagnostic and prognostic ability, and either method c”